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Abstract
Background: In-hospital cardiac arrest has a poor prognosis despite active electrocardiography monitoring. The
initial rhythm of approximately 25% of in-hospital cardiopulmonary resuscitation (CPR) events is pulseless
ventricular tachycardia/ventricular fibrillation (VT/VF). Early defibrillation is an independent predictor of survival
in CPR events caused by VT/VF. The automated external cardioverter defibrillator (AECD) is a device attached
by pads to the chest wall that monitors, detects, and within seconds, automatically delivers electric countershock
to an appropriate tachyarrhythmia.
Study Objectives: • To evaluate safety of AECD monitoring in hospitalized patients.
• To evaluate whether AECDs provide earlier defibrillation than hospital code teams.
Methods: The study is a prospective trial randomizing patients admitted to the telemetry ward to standard CPR
(code team) or standard CPR plus AECD monitoring (PowerHeart CRM). The AECD is programmed to deliver
one 150 J biphasic shock to patients in sustained VT/VF. Data is collected using the Utstein criteria for cardiac
arrest. The primary endpoint is time-to-defibrillation; secondary outcomes include neurological status and survival
to discharge, with 3-year follow-up.
Results: To date, 192 patients have been recruited in the time period between 10/10/2006 to 7/20/2007. A total
of 3,655 hours of telemetry data have been analyzed in the AECD arm. The AECD has monitored ambulatory
telemetry patients in sinus rhythm, sinus tachycardia, supraventricular tachycardia, atrial flutter or fibrillation, with
premature ventricular complexes and non-sustained VT without delivery of inappropriate shocks. One patient
experienced sustained VT during AECD monitoring, who was successfully defibrillated (17 seconds after meeting
programmed criteria). There are no events to report in the control arm. The patient survived the event without
neurological complications. During the same time period, mean time to shock for VT/VF cardiac arrest occurring
outside the telemetry ward was 230 ± 50 seconds.
Conclusion:  AECD monitoring is safe and likely results in earlier defibrillation than standard telemetry
monitoring.
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Background
In-hospital cardiac arrest has a poor prognosis despite
active electrocardiography monitoring. Part of the poor
prognosis may be explained by slow response to a lethal
arrhythmia.[1] The National Registry of Cardiopulmo-
nary Resuscitation (NRCPR) has reported delayed defi-
brillation, which was defined as greater than 2 minutes, in
more than 30% of cases of in-hospital cardiac arrest. This
delay in defibrillation resulted in significantly lower prob-
ability of surviving to hospital discharge.[1]
The initial rhythm in about 25% of in-hospital cardiac
arrest is ventricular tachycardia or fibrillation (VT/VF).[2]
Early provision of good quality CPR and rapid defibrilla-
tion have the highest impact on survival for the victims of
VT/VF cardiac arrest.[3] Early defibrillation is an inde-
pendent predictor of survival in CPR events caused by VT/
VF.[4,5] Delay in provision of defibrillation for 10 min-
utes renders CPR ineffective.[4] Each minute of delay in
defibrillation increases the likelihood of death by 7% to
10% in cardiac arrest.[5] If defibrillation is provided
within 3 minutes in in-hospital cardiac arrest, 38% sur-
vival to discharge is reported versus 21%, if defibrillation
is provided after 3 minutes.[2] Addressing this delay, a
program encouraging early defibrillation using auto-
mated external defibrillators (AED) in the hospital
resulted in a 14-fold increase in survival for VT/VF cardiac
arrest.[6]
Automated External Cardioverter Defibrillator (AECD;
The PowerHeart CRM, Cardiac Science Inc., Seattle, WA)
is a device attached to the chest wall by pads, monitors the
electrocardiogram, and is capable of automatically deliv-
ering electric countershock to appropriate rhythms with-
out operator intervention. Automated external
cardioverter defibrillators have been studied in a few non-
randomized clinical trials. [7-9] They performed with a
sensitivity of 100% and a specificity of 98.8% in a study
conducted in the United States (n = 79) and a sensitivity
of 100% and a specificity of 97.6% in an European study
(n = 117).[7,8] We designed the current randomized trial
to test the safety of AECDs in hospitalized patients and the
performance compared to standard telemetry response.
Methods
This study is a single center, randomized, prospective, trial
in which, all patients admitted to the emergency depart-
ment and telemetry unit of the Atlanta Veterans Affairs
Medical Center (AVAMC), Decatur, Georgia are screened.
Patient recruitment started in October 2006. Inclusion
and exclusion criteria are presented in Table 1. Patients
consenting to participate in the study are randomized to
either standard electrocardiographic telemetry or standard
Table 1: Inclusion and Exclusion Criteria
Inclusion Criteria:
1. All patients admitted to telemetry ward and ER.
2. Age > 18 years.
Exclusion Criteria:
1. Pregnant women.
2. Patients with R wave less than 0.5 mV in lead II.
3. Patients with functioning ICDs.
4. Patients with cardiac pacemakers if oversensing by AECD is demonstrated (double counting of pacer spikes).
5. Patients with visible chest lesions that would prevent AECD pad placement.
6. Patients who are designated DNR.
7. Right bundle branch block.
8. Patients with Parkinson's disease.
9. Patients with seizure disorders.
Additional Exclusion Criteria for Emergency Room:
10. Patients with dementia and/or delirium.
11. Patients presenting with psychiatric complaints.
12. Patients who are agitated.
13. Patients presenting with trauma.
14. Patients unable to participate in the informed consent process.
15. Patients with respiratory rate greater than twenty.
16. Patients who report pain greater than four out of ten in the visual analog scale.
ER = emergency room; ICD = internal cardioverter defibrillator; AECD = automated external cardioverter defibrillator; DNR = do not resuscitateTrials 2008, 9:36 http://www.trialsjournal.com/content/9/1/36
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telemetry augmented by AECD monitoring (Figure 1).
Patients randomized to AECD monitoring have the AECD
attached for the duration of their hospitalization while
undergoing simultaneous telemetry monitoring. A log
book is used to record the time of AECD attachment and
to record whenever the AECD is detached from the
patient. The AECD is programmed to deliver a single 150
Joule shock to VT/VF rhythms presenting above the rate of
170 beats per minute, after a 30 second delay. Study
enrollment terminates when telemetry is discontinued.
The primary endpoint is time-to-defibrillation in VT/VF
cardiac arrest. The AECDs have the ability to measure the
precise time of initiation of cardiac arrhythmias and of
delivery of defibrillation. The secondary outcomes are sur-
vival to discharge and cerebral outcomes as measured by
cerebral performance category scale (Table 2). Patients
who survive cardiac arrest while participating in the trial
will be followed for a period of three years for survival,
internal cardioverter defibrillator (ICD) placement and
cerebral performance. The Emory University Institutional
Review Board (IRB) and the AVAMC Research and Devel-
opment Committee approved the study.
Data collection
Demographic and arrest data is collected according to
Utstein guidelines and stored in a database designed with
Microsoft access software (Microsoft Inc., Redmond, WA).
Sample size
A total sample size of 40 patients per group will be
recruited. There are approximately 40 true cardiac arrests
per year on the telemetry ward. The expected time to defi-
brillation in the AECD group is to be 30 ± 30 seconds,
whereas time to defibrillation in the standard of care
group is 180 ± 180 seconds. The expected time to defibril-
lation in the AECD group will be programmed into the
device. Time to defibrillation will be coded continuously
in both groups. Using a two-tailed t-test to compare time
to defibrillation between the groups, a sample size of 12
patients per group affords 81% power at alpha = 0.05. A
total sample size of 40 patients per group will yield over
99% power for a two-tailed test at alpha = 0.05.
Statistical analysis
The primary outcome will be time-to-defibrillation.
Demographic and clinical categorical and continuous var-
iables are compared for patients in the standard of care
versus the AECD group at cardiac arrest. Baseline data will
be expressed as mean ± SD for continuous variables, and
frequencies for categorical variables. Differences in base-
line characteristics between the groups will be examined
by the use of χ2 tests and two-sample t-tests, or, if assump-
tions are not met, by Fisher's Exact and Mann-Whitney
tests for categorical and continuous variables, respec-
tively. Time to defibrillation will be measured continu-
ously in both the standard of care and the AECD group,
Design of the AECD Trial Figure 1
Design of the AECD Trial. ED = emergency department; 
AECD = automated external cardioverter defibrillator; VT/
VF = ventricular tachycardia/ventricular fibrillation.
Patients Admitted to Telemetry Ward/ED
Arm A: Standard of Care Arm B: AECD Monitoring
+ Standard of care
VT/VF 
Outcomes 
Time to First Shock 
Survival
Neurological Status 
Table 2: Cerebral Performance Categories/CPC scale
CPC 1: Good cerebral performance – conscious, alert, able to work, might have mild neurologic or psychological deficit.
CPC 2: Moderate cerebral disability – conscious, sufficient cerebral function for independent activities of daily life. Able to work in sheltered 
environment.
CPC 3: Severe cerebral disability – conscious, dependent on others for daily support because of impaired brain function. Ranges from ambulatory 
state to severe dementia or paralysis.
CPC 4: Coma or vegetative state – any degree of coma without the presence of all brain death criteria. Unawareness, even if appears awake 
(vegetative state) without interaction with environment; may have spontaneous eye opening and sleep/awake cycles. Cerebral unresponsiveness.
CPC 5: Brain death – apnea, areflexia, EEG silence, etc.
EEG = electroencephalogramTrials 2008, 9:36 http://www.trialsjournal.com/content/9/1/36
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then compared using a two-tailed t-test. Assumptions will
be checked and analyses will be adjusted accordingly.
In addition a multiple logistic model will be used to ana-
lyze the secondary endpoints (survival of cardiac arrest,
survival to discharge), considering all the available varia-
bles. The total sample size will limit this analysis; how-
ever, an exploratory forward stepwise selection procedure
will be used with a p-value of at least 0.10 for entry and
0.05 for removal. All pairwise interactions between AECD
use and the other variables in the final stepwise model
will be tested. A Hosmer-Lemeshow test will be used to
test goodness of fit. Odds ratios will be presented with
95% confidence intervals. Pearson residuals, deviance
residuals, and influence statistics will be examined to
assess model fit. Statistical analyses will be performed
using SAS version 9.1.3.
Cerebral performance state (Table 2) will be measured
using the cerebral performance categorization (CPC) scale
and analyzed initially using χ2 tests. If cell counts warrant,
the 2 × 3 contingency table will be analyzed using exact
methods and the mean score statistics (Q) will be used to
compare cerebral performance status between the groups.
Preliminary results
One hundred and ninety two patients were recruited in
the time period between 10/10/2006 to 7/20/2007. The
demographic and clinical characteristics of the patients
are presented in Table 3. Patients in the control and treat-
ment arms had similar characteristics. The majority of
patients (> 90%) in both arms were men, reflecting the
demographics of the AVAMC. A total of 3,655 hours of
telemetry data has been analyzed by the AECDs. The
AECDs monitored ambulatory patients with normal sinus
rhythm, sinus tachycardia, atrial fibrillation or flutter,
supraventricular tachycardia, premature ventricular com-
plexes and non-sustained ventricular tachycardia without
inappropriately delivering a shock (Table 4). Of the 95
patients randomized to the AECD arm, total of ten
patients had to be taken off the AECD, two due to adverse
events, two due to anxiety, two due to skin irritation by
the pads, and four due to alarming of the AECD, as the
pads detached from the chest wall during their sleep.
Only one event of sustained VT occurred in the experi-
mental arm, which was defibrillated by the AECD 17 sec-
onds after programmed criteria were met (Figure 2). There
are no events to report in the control arm. During the
same time period mean time to shock for VT/VF cardiac
arrest occurring outside the telemetry ward was 230 ± 50
seconds.
There were two false positive events in which, the shocks
were delivered inappropriately. In the first case, the AECD
delivered the shock when a patient was eating an apple.
Table 3: Demographic and Clinical Characteristics of Study Subjects
AECD n = 95 Control n = 97 P Value
Age ± SD 61.7 ± 3.4 62 ± 3.4 0.7
Gender 0.98
Male 92 (96.8%) 94 (96.9%)
Female 3 (3.2%) 3 (3.1%)
Race 0.15
Hispanic 2 (2.1%) 0
White 42 (44.2%) 53 (54.6%)
Black 51 (53.7%) 44 (45.4%)
History of HF 25 (26.3%) 20 (20.6%) 0.39
New Diagnosis of HF 6 (6.3%) 4 (4.1%) 0.53
Diabetes mellitus 46 (48.4%) 35 (36.1%) 0.11
History of CAD 35 (36.8%) 42 (43.3%) 0.38
Hypertension 79 (84%) 74 (76.3%) 0.28
Hyperlipidemia 55 (57.9%) 53 (54.6%) 0.66
EKG on admission 0.62
NSR 84 (88.4%) 81 (83.5%)
Atrial fibrillation/flutter 9 (9.5%) 11 (11.3%)
SVT 02  ( 2 . 1 % )
Other 2 (2.1%) 3 (3.1%)
SD = standard deviation; HF = heart failure; CAD = coronary artery disease; NSR = normal sinus rhythm; SVT = supraventricular tachycardia
Table 4: Frequency of Abnormal Rhythms Monitored by the 
AECD
Atrial Fibrillation/Flutter 9 (9.5%)
Supraventricular Tachycardia 1 (1.1%)
Premature Ventricular Complexes 10 (10.5%)
Non-Sustained Ventricular Tachycardia 5 (5.3%)
AECD = automated external cardioverter defibrillatorTrials 2008, 9:36 http://www.trialsjournal.com/content/9/1/36
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The AECD showed ventricular fibrillation at the same
time the telemetry monitor showed sinus rhythm. This
occurred in the setting of a reduced R wave amplitude on
his 12-lead EKG, which was less than 0.5 mV. In the sec-
ond case, discharge was the result of deliberate action of
the patient. Neither patient had any other complications
related to the delivery of the shocks.
The AECD correctly recognized sustained monomorphic ventricular tachycardia and delivered a 150 Joule shock after 47 sec- onds Figure 2
The AECD correctly recognized sustained monomorphic ventricular tachycardia and delivered a 150 Joule shock after 47 sec-
onds. The rhythm is converted to sinus rhythm but reverts to ventricular tachycardia after 10 seconds. (= capacitor charging; # 
= capacitor charged; * = therapy delivered to patient.Publish with BioMed Central    and   every 
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Discussion
In-hospital cardiac arrest remains a major health problem
with high mortality rates.[2] Most important determi-
nants of survival in both out-of-hospital and in-hospital
cardiac arrest are early CPR and defibrillation.[1-3,10-12]
Previously three clinical studies evaluated the application
of AECD technology in hospitalized patients. [7-9] Mat-
tioni et al. and Martinez-Rubio et al. both demonstrated
high sensitivity and specificity for the AECD in the treat-
ment of tachyarrhythmias.[7,8] The two studies demon-
strated time-to-shock in the range of 14 to 22 seconds in
patients admitted to the intensive care units and the car-
diac electrophysiology laboratory.[7,8] In another study
in patients with cardiovascular diagnoses admitted to the
emergency department, a 94.4% success rate, with a mean
time-to-shock of 33.4 seconds for VT/VF arrhythmias was
found.[9] These studies, while demonstrating effective-
ness of AECDs in highly specialized settings, did not
establish efficacy in an ambulatory group, where the pos-
sibility of inappropriate discharges are increased. In addi-
tion, none of the studies were randomized; there were no
control groups with standard of care; and finally, none of
the previous studies evaluated the impact of AECDs on
survival and cerebral outcomes.
In the one arrest monitored by AECD, we showed a defi-
brillation time of 17 seconds. This is consistent with pre-
vious AECD trials. On the other hand, Chan and his
coauthors reported that in 30% of in-hospital cardiac
arrest, defibrillation is delayed using standard therapy,
resulting in lower survival to discharge (22.2% vs 39.3%,
P =< 0.001).[1] After hours (5 p.m. to 8 a.m.), weekends
and unmonitored beds were predictors of delayed defi-
brillation, suggesting that manpower considerations were
a critical determinant of response.[1,13] It would seem
likely that routine use of automated strategies would help
addressing these delays.[14] This idea is supported by
findings that AEDs can improve outcomes in in-hospital
cardiac arrest.[6]
Our trial thus far, has established the safety and practical-
ity of continuous monitoring by AECDs in a high risk,
ambulatory, inpatient population. Having established
efficacy, continuation of the trial will allow a comparison
of outcomes between the two strategies.
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